| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.2592 |
| P698 | PubMed publication ID | 19621337 |
| P50 | author | Dong Seok Lee | Q83477553 |
| P2093 | author name string | Jin-Man Kim | |
| Dae-Yeul Yu | |||
| Soo-Ho Choi | |||
| Hyung-Bae Moon | |||
| Kyung-Hyun Cho | |||
| Ai-Guo Wang | |||
| Ying-Hao Han | |||
| Hye-Lin Ha | |||
| Soon B Hwang | |||
| Dae-Ghon Kim | |||
| P2860 | cites work | Transgenic technology and the study of hepatitis viruses: a review of what we have learned | Q34076924 |
| High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport | Q34123188 | ||
| Expression of hepatitis C virus nonstructural 4B in transgenic mice | Q38509622 | ||
| Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice | Q38515296 | ||
| Hepatitis C virus core protein induces hepatic steatosis in transgenic mice | Q42983905 | ||
| Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth | Q42993783 | ||
| P433 | issue | 2 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| hepatitis C | Q154869 | ||
| P304 | page(s) | 253-262 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice | |
| P478 | volume | 219 |
| Q38619642 | DNA damage response and sphingolipid signaling in liver diseases |
| Q36373621 | Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice |
| Q38001126 | Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? |
| Q28742429 | HBV inhibits apoB production via the suppression of MTP expression |
| Q43040452 | HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis |
| Q34765478 | Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. |
| Q40141993 | Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response |
| Q41682315 | Hepatitis C virus NS5A protein enhances gluconeogenesis through upregulation of Akt-/JNK-PEPCK signalling pathways |
| Q38778157 | Hepatitis C virus NS5A protein interacts with lysine methyltransferase SET and MYND domain-containing 3 and induces activator protein 1 activation |
| Q24339370 | Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation |
| Q56917098 | Hepatitis C virus and hepatocellular carcinoma |
| Q45360614 | Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions |
| Q38072721 | Hepatitis C virus diversity and hepatic steatosis |
| Q58089566 | Hepatitis C virus downregulates ubiquitin conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage |
| Q30395512 | Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway |
| Q30393729 | Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α. |
| Q35505394 | Hepatitis C virus infection: molecular pathways to insulin resistance |
| Q37447666 | Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response |
| Q26766119 | Hepatitis C virus relies on lipoproteins for its life cycle |
| Q36236839 | How do persistent infections with hepatitis C virus cause liver cancer? |
| Q24308039 | Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion |
| Q37788976 | Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. |
| Q36457831 | Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. |
| Q64977889 | Mechanisms of hepatocarcinogenesis in chronic hepatitis C. |
| Q30395601 | Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders |
| Q36255920 | Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver |
| Q52347275 | Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis. |
| Q39365313 | Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation |
| Q40429665 | Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer |
| Q33904328 | Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma |
| Q56972496 | Roles of p53 in extrinsic factor-induced liver carcinogenesis |
| Q37800793 | Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets |
| Q34221618 | Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis |
| Q36812745 | Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer |
Search more.